The page lists 18 projects related to the topic "bm".
| # | |||
|---|---|---|---|
| 1 | UNICAT | Unique Biomaterial-Drug Solution for Multifunctional Central Venous Catheters | 2015 |
| 2 | ENviSION | EmpoweriNg (European) SME business model InnovatiON | 2015 |
| 3 | By-BM | By-products for Building Materials | 2016 |
| 4 | NVHSC | Neurovascular interplay in the hematopoietic stem cell niches in homeostasis and myeloproliferative neoplasias | 2016 |
| 5 | BioMEP | Biomedical Engineering and Medical Physics | 2016 |
| 6 | MADIA | Magnetic DIagnostic Assay for neurodegenerative diseases | 2017 |
| 7 | RESPINE | REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy | 2017 |
| 8 | BioMedBC | Molecular profiling of Bladder Cancer to support personalized medicine | 2017 |
| 9 | deFIBER | Dissecting the cellular and molecular dynamics of bone marrow fibrosis for improved diagnostics and treatment | 2018 |
| 10 | ELIMINATE | Development of strategies to eliminate cancer cells from the bone marrow | 2018 |
| 11 | CELION | Circular Economy applied to LI-ION batteries for smart electric mobility in cities | 2017 |
| 12 | CXCR4THERAPY | IMPROVING HEMATOPOIETIC STEM CELL- BASED GENE THERAPY OUTCOME BY MODULATING CXCR4 EXPRESSION | 2018 |
| 13 | DCPOIESIS | Steady-state and demand-driven dendritic cell generation | 2018 |
| 14 | bECOMiNG | spontaneous Evolution and Clonal heterOgeneity in MoNoclonal Gammopathies: from mechanisms of progression to clinical management | 2019 |
| 15 | Brillouin4Life | Development of advanced optical tools for studying cellular mechanics at high spatial and temporal resolution | 2020 |
| 16 | LINKER | Elucidating transcriptional rewiring on hematological malignancies via computational methods | 2020 |
| 17 | IC-CCD-qHSC | Intrapopulation communication and collective cell decisions of hematopoietic stem cells | 2020 |
| 18 | Hemstem | Targeting leukaemia by modulating hematopoietic stem cell competitiveness | 2020 |